Warren Averett Asset Management, LLC Biocryst Pharmaceuticals Inc Transaction History
Warren Averett Asset Management, LLC
- $5.34 Billion
- Q3 2024
A detailed history of Warren Averett Asset Management, LLC transactions in Biocryst Pharmaceuticals Inc stock. As of the latest transaction made, Warren Averett Asset Management, LLC holds 19,713 shares of BCRX stock, worth $151,198. This represents 0.0% of its overall portfolio holdings.
Number of Shares
19,713
Previous 19,713
-0.0%
Holding current value
$151,198
Previous $121,000
23.14%
% of portfolio
0.0%
Previous 0.0%
Shares
10 transactions
Others Institutions Holding BCRX
# of Institutions
278Shares Held
172MCall Options Held
625KPut Options Held
739K-
Vanguard Group Inc Valley Forge, PA20.3MShares$156 Million0.0% of portfolio
-
Black Rock Inc. New York, NY20MShares$153 Million0.0% of portfolio
-
Avoro Capital Advisors LLC New York, NY11.9MShares$91 Million1.36% of portfolio
-
Kynam Capital Management, LP Princeton, NJ9.09MShares$69.7 Million5.66% of portfolio
-
State Street Corp Boston, MA8.85MShares$67.9 Million0.0% of portfolio
About BIOCRYST PHARMACEUTICALS INC
- Ticker BCRX
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 185,944,992
- Market Cap $1.43B
- Description
- BioCryst Pharmaceuticals, Inc., a biotechnology company, discovers novel, oral, and small-molecule medicines. The company markets peramivir injection, an intravenous neuraminidase inhibitor for the treatment of acute uncomplicated influenza under the RAPIVAB, RAPIACTA, and PERAMIFLU names; and ORLADEYO, an oral serine protease inhibitor to treat...